Cargando…

Coronavirus Disease 2019 (COVID‐19) Pandemic Implications in Pediatric and Adult Congenital Heart Disease

The corona virus disease ‐2019 (COVID‐19) is a recently described infectious disease caused by the severe acute respiratory syndrome corona virus 2 with significant cardiovascular implications. Given the increased risk for severe COVID‐19 observed in adults with underlying cardiac involvement, there...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alsaied, Tarek, Aboulhosn, Jamil A., Cotts, Timothy B., Daniels, Curt J., Etheridge, Susan P., Feltes, Timothy F., Gurvitz, Michelle Z., Lewin, Mark B., Oster, Matthew E., Saidi, Arwa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Contemporary Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7429046/ https://www.ncbi.nlm.nih.gov/pubmed/32441586 http://dx.doi.org/10.1161/JAHA.120.017224

Ejemplares similares

The cardiovascular burden of coronavirus disease 2019 (COVID-19) with a focus on congenital heart disease
por: Tan, Weiyi, et al.
Publicado: (2020)

Health Care Policy and Congenital Heart Disease: 2020 Focus on Our 2030 Future
por: Chowdhury, Devyani, et al.
Publicado: (2021)

Guidance on Short‐Term Management of Atrial Fibrillation in Coronavirus Disease 2019
por: Rattanawong, Pattara, et al.
Publicado: (2020)

Coronavirus Disease 2019 and the Cerebrovascular‐Cardiovascular Systems: What Do We Know So Far?
por: Larson, Anthony S., et al.
Publicado: (2020)

Coronavirus Disease 2019–Associated Thrombosis and Coagulopathy: Review of the Pathophysiological Characteristics and Implications for Antithrombotic Management
por: Ortega‐Paz, Luis, et al.
Publicado: (2021)

Epigenetics in Congenital Heart Disease
por: Wang, Guanglei, et al.
Publicado: (2022)

Management of Cardiovascular Risk Factors in Adults With Congenital Heart Disease
por: Lui, George K., et al.
Publicado: (2014)

Atrioventricular Valve Regurgitation in Single Ventricle Heart Disease: A Common Problem Associated With Progressive Deterioration and Mortality
por: Tseng, Stephanie Y., et al.
Publicado: (2020)

Advances in the Understanding of the Genetic Determinants of Congenital Heart Disease and Their Impact on Clinical Outcomes
por: Russell, Mark W., et al.
Publicado: (2018)

Maternal Obesity and Diabetes Mellitus as Risk Factors for Congenital Heart Disease in the Offspring
por: Helle, Emmi, et al.
Publicado: (2020)

Epicardial and Perivascular Adipose Tissues and Their Influence on Cardiovascular Disease: Basic Mechanisms and Clinical Associations
por: Fitzgibbons, Timothy P., et al.
Publicado: (2014)

Databases for Congenital Heart Defect Public Health Studies Across the Lifespan
por: Riehle‐Colarusso, Tiffany J., et al.
Publicado: (2016)

Response to the letter, “The cardiovascular burden of congenital heart disease - not only in times of COVID-19”
por: Tan, Weiyi, et al.
Publicado: (2020)

Highly Sensitive Cardiac Troponins: The Evidence Behind Sex‐Specific Cutoffs
por: Bhatia, Prerana M., et al.
Publicado: (2020)

Evaluation of the Relationship Between a Chronic Disease Care Management Program and California Pay-for-Performance Diabetes Care Cholesterol Measures in One Medical Group
por: Cutler, Timothy W., et al.
Publicado: (2007)

Impact of Right-Sided-Catheter-Based Valve Implantation on Decision-Making in Congenital Heart Disease
por: Ghobrial, Joanna, et al.
Publicado: (2016)

Diagnosis and Management of Cardiovascular Disease in Advanced and End‐Stage Renal Disease
por: Bhatti, Navdeep K., et al.
Publicado: (2016)

Sick Individuals and Sick Populations by Geoffrey Rose: Cardiovascular Prevention Updated
por: Sniderman, Allan D., et al.
Publicado: (2018)

Cardiac Conduction System in Congenitally Corrected Transposition of the Great Arteries and Its Clinical Relevance
por: Baruteau, Alban‐Elouen, et al.
Publicado: (2017)

The Evolution of Disease State Management: Historical Milestones and Future Directions
por: N’Dri, Laetitia A., et al.
Publicado: (2020)

Alzheimer's disease: Newer biomarkers
por: Dangi, Ankit, et al.
Publicado: (2021)

Sex Differences in Cardiovascular Disease and Cognitive Impairment: Another Health Disparity for Women?
por: Volgman, Annabelle Santos, et al.
Publicado: (2019)

Unraveling the Genotype‐Phenotype Relationship in Hypertrophic Cardiomyopathy: Obesity‐Related Cardiac Defects as a Major Disease Modifier
por: Nollet, Edgar E., et al.
Publicado: (2020)

Gene Therapy to Treat Cardiovascular Disease
por: Wolfram, Julie A., et al.
Publicado: (2013)

Role of Heme in Cardiovascular Physiology and Disease
por: Sawicki, Konrad Teodor, et al.
Publicado: (2015)

The Emerging Role of Irisin in Cardiovascular Diseases
por: Fu, Jinjuan, et al.
Publicado: (2021)

Pregnancy Complicated by Valvular Heart Disease: An Update
por: Nanna, Michael, et al.
Publicado: (2014)

Management of Left Main Coronary Artery Disease
por: Ramadan, Ronnie, et al.
Publicado: (2018)

Cardiovascular Diseases That Have Emerged From the Darkness
por: Maron, Barry J., et al.
Publicado: (2021)

What Is the Best Mix of Population‐Wide and High‐Risk Targeted Strategies of Primary Stroke and Cardiovascular Disease Prevention?
por: Feigin, Valery L., et al.
Publicado: (2020)

Clinician's Guide to the Updated ABCs of Cardiovascular Disease Prevention
por: Kohli, Payal, et al.
Publicado: (2014)

Physical Activity in the Prevention and Treatment of Coronary Artery Disease
por: Winzer, Ephraim Bernhard, et al.
Publicado: (2018)

Examining the Paracrine Effects of Exosomes in Cardiovascular Disease and Repair
por: Gartz, Melanie, et al.
Publicado: (2018)

Radiation‐Induced Cardiovascular Disease: Review of an Underrecognized Pathology
por: Belzile‐Dugas, Eve, et al.
Publicado: (2021)

Locking the Revolving Door: Racial Disparities in Cardiovascular Disease
por: Velarde, Gladys, et al.
Publicado: (2023)

Lipid Levels and Use of Lipid-Lowering Drugs for Patients in Pharmacist-Managed Lipid Clinics Versus Usual Care in 2 VA Medical Centers
por: Mazzolini, Timothy A., et al.
Publicado: (2005)

Insights Into Aortic Sclerosis and Its Relationship With Coronary Artery Disease
por: Milin, Alexandra C., et al.
Publicado: (2014)

Defining a Mobile Health Roadmap for Cardiovascular Health and Disease
por: Eapen, Zubin J., et al.
Publicado: (2016)

Ischemia and No Obstructive Coronary Artery Disease (INOCA): What Is the Risk?
por: Herscovici, Romana, et al.
Publicado: (2018)

Artificial Intelligence: Practical Primer for Clinical Research in Cardiovascular Disease
por: Kagiyama, Nobuyuki, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_u3rer8q01r88r4v4a1acjsvjt4